Last updated on September 2017

A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia


Brief description of study

The objective of this study is to evaluate the efficacy and the safety when ASP1517 is intermittently administered in Erythropoiesis Stimulating Agent (ESA)-untreated non-dialysis chronic kidney disease patients with anemia.

Clinical Study Identifier: NCT02964936

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Astellas Pharma Inc.

Site JP00007
Aichi, Japan
  Connect »

Astellas Pharma Inc.

Site JP00018
Aichi, Japan
  Connect »

Astellas Pharma Inc.

Site JP00028
Aichi, Japan
  Connect »

Astellas Pharma Inc.

Site JP00001
Chiba, Japan
  Connect »

Astellas Pharma Inc.

Site JP00035
Ehime, Japan
  Connect »

Astellas Pharma Inc.

Site JP00012
Fukui, Japan
  Connect »

Astellas Pharma Inc.

Site JP00011
Fukuoka, Japan
  Connect »

Astellas Pharma Inc.

Site JP00031
Fukuoka, Japan
  Connect »

Astellas Pharma Inc.

Site JP00030
Hiroshima, Japan
  Connect »

Astellas Pharma Inc.

Site JP00034
Hiroshima, Japan
  Connect »

Astellas Pharma Inc.

Site JP00036
Hiroshima, Japan
  Connect »

Astellas Pharma Inc.

Site JP00005
Hokkaido, Japan
  Connect »

Astellas Pharma Inc.

Site JP00020
Hyogo, Japan
  Connect »

Astellas Pharma Inc.

Site JP00015
Ibaraki, Japan
  Connect »

Astellas Pharma Inc.

Site JP00017
Ibaraki, Japan
  Connect »

Astellas Pharma Inc.

Site JP00021
Ibaraki, Japan
  Connect »

Astellas Pharma Inc.

Site JP00025
Ibaraki, Japan
  Connect »

Astellas Pharma Inc.

Site JP00037
Ibaraki, Japan
  Connect »

Astellas Pharma Inc.

Site JP00033
Ishikawa, Japan
  Connect »

Astellas Pharma Inc.

Site JP00029
Iwate, Japan
  Connect »

Astellas Pharma Inc.

Site JP00006
Kanagawa, Japan
  Connect »

Astellas Pharma Inc.

Site JP00014
Kanagawa, Japan
  Connect »

Astellas Pharma Inc.

Site JP00038
Kanagawa, Japan
  Connect »

Astellas Pharma Inc.

Site JP00010
Miyagi, Japan
  Connect »

Astellas Pharma Inc.

Site JP00016
Nagano, Japan
  Connect »

Astellas Pharma Inc.

Site JP00024
Niigata, Japan
  Connect »

Astellas Pharma Inc.

Site JP00032
Oita, Japan
  Connect »

Astellas Pharma Inc.

Site JP00003
Osaka, Japan
  Connect »

Astellas Pharma Inc.

Site JP00009
Osaka, Japan
  Connect »

Astellas Pharma Inc.

Site JP00026
Osaka, Japan
  Connect »

Astellas Pharma Inc.

Site JP00002
Saitama, Japan
  Connect »

Astellas Pharma Inc.

Site JP00019
Saitama, Japan
  Connect »

Astellas Pharma Inc.

Site JP00027
Saitama, Japan
  Connect »

Astellas Pharma Inc.

Site JP00004
Tokyo, Japan
  Connect »

Astellas Pharma Inc.

Site JP00013
Tokyo, Japan
  Connect »

Astellas Pharma Inc.

Site JP00022
Tokyo, Japan
  Connect »

Astellas Pharma Inc.

Site JP00023
Tokyo, Japan
  Connect »

Astellas Pharma Inc.

Site JP00008
Toyama, Japan
  Connect »